Back
Apellis Pharmaceuticals Stock Price Chart
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Sell
33
APLS
Apellis Pharmaceuticals
Last Price:
26.19
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.63 | Sell |
| 20-day SMA: | 27.95 | Sell |
| 50-day SMA: | 30.19 | Sell |
| 200-day SMA: | 43.29 | Sell |
| 8-day EMA: | 28.09 | Sell |
| 20-day EMA: | 28.31 | Sell |
| 50-day EMA: | 30.23 | Sell |
| 200-day EMA: | 40.03 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 36.3 | Sell |
| Chaikin Money Flow: | -4148679 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.02 - 28.78) | Sell |
| Bollinger Bands (100): | (29.08 - 39.08) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 26.27 while APLS 8-day simple moving average is 28.63, which is a Sell signal.
- The stock price of APLS is 26.27 while Apellis Pharmaceuticals 20-day SMA is 27.95, which makes it a Sell.
- Apellis Pharmaceuticals 50-day simple moving average is 30.19 while APLS share price is 26.27, making it a Sell technically.
- APLS stock price is 26.27 and Apellis Pharmaceuticals 200-day simple moving average is 43.29, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a Sell
The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
3.27B
Price in USD:
26.27
Share Volume:
5.5M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
73.80
52-Week Low:
24.34
Sell
33
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?
The Apellis Pharmaceuticals stock price is 26.27 USD today. -
Will APLS stock go up or go down?
Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Apellis Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
- Apellis Pharmaceuticals share price is 26.27 while APLS 8-day exponential moving average is 28.09, which is a Sell signal.
- The stock price of APLS is 26.27 while Apellis Pharmaceuticals 20-day EMA is 28.31, which makes it a Sell.
- Apellis Pharmaceuticals 50-day exponential moving average is 30.23 while APLS share price is 26.27, making it a Sell technically.
- APLS stock price is 26.27 and Apellis Pharmaceuticals 200-day simple moving average is 40.03, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
- APLS Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Apellis Pharmaceuticals is a Sell
- Apellis Pharmaceuticals Relative Strength Index (RSI) is 36.3, which suggest Apellis Pharmaceuticals is oversold
- The Bollinger Bands (25) for Apellis Pharmaceuticals is (27.02 - 28.78), which suggest Apellis Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Apellis Pharmaceuticals is (29.08 - 39.08), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.